81 results
IDSA Aspergillosis Treatment
 ā€¢ Invasive pulmonary aspergillosis (IPA)
 ā€¢ CNS aspergillosis
 ā€¢ Cardiac Aspergillus infection
 ā€¢
IDSA Aspergillosis ... Treatment ā€¢ Invasive ... Aspergillosis #Treatment ... #management #pharmacology ... #IDSA
IDSA Treatment of Necrotizing Infections of the Skin, Fascia, and Muscle
 ā€¢ Mixed infections
 ā€¢ Streptococcus
IDSA Treatment of ... Necrotizing Infections ... fasciitis #Skin #IDSA ... #Treatment #management ... #antibiotics #pharmacology
IDSA - Antimicrobial Therapy for Staphylococcal and Streptococcal Skin and Soft Tissue Infections
 ā€¢ Impetigo (Staphylococcus
IDSA - Antimicrobial ... and Soft Tissue Infections ... Streptococcal #Antibiotics ... #management #treatment ... #idsa #cellulitis
IDSA Surgical Wound Infection Algorithm
Algorithm for the management and treatment of surgical site infections (SSIs). 
*For
IDSA Surgical Wound ... Algorithm for the management ... and treatment of ... allergy to Ī²-lactam antibiotics ... #Algorithm #IDSA
IDSA Suggested Empiric Antibiotic Regimens Based on Clinical Severity for Diabetic Foot Infections
Mild (usually treated with
IDSA Suggested Empiric ... Antibiotic Regimens ... Based on Clinical ... #pharmacology # ... idsa #podiatry
Antibiotics for Intraabdominal Infection. 
Use your local antimicrobial susceptibility data for selecting the best empiric treatment!
Antibiotics for ... AAST 2021 global clinical ... infectiousdiseases #management ... #pharmacology # ... treatment
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Antimicrobial Treatment ... Parenteral #IV #Antibiotics ... Osteomyelitis #management ... #treatment #pharmacology ... #idsa
IDSA Algorithm for the Management of Purulent skin and soft tissue infections (SSTIs). 
Mild infection: for
IDSA Algorithm for ... the Management ... treatment or those ... or those with clinical ... #cellulitis #idsa
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... fluoroquinolone #IDSA ... Acquired #Pneumonia #Antibiotics ... #Management #Guidelines ... #pharmacology
IDSA 2017 CDiff Guidelines - TableĀ 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Clostridium difficile infection ... Episode #Pharmacology ... #Management #CDiff ... IDSA2017 #Adjunct #Antibiotics